Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$684,874
+$94,382 QoQ
Shares Held
571
-11.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#3,471
of 4,605 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2025CallValue
$1,238,865
CallShares
1,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FreeGulliver LLC holds $1,815,819 across 5 Drug Manufacturers - General names. LLY ranks #1 (37.7% of the industry book) .
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $684,874 | 571 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $590,492 | 642 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $663,077 | 617 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $354,032 | 464 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $100,761 | 122 | Shares | Sole | 2025-05-06 | |
| 2025-03-31 | $1,238,865 | 1,500 | Call | Sole | 2025-05-06 | |
| 2024-12-31 | $237,004 | 307 | Shares | Sole | 2025-02-11 | |
| 2024-12-31 | $13,432,800 | 17,400 | Call | Sole | 2025-02-11 | |
| 2024-09-30 | $230,344 | 260 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||